New Siemens software helps to correct cardiac fibrillations

SIEMENSWorldwide, five percent of all people over the age of 65 suffer from atrial fibrillation. While cardiac arrhythmia can be treated with medication, patients have to take it for the rest of their lives. Ablation therapy offers an alternative: myocardial cells in the left atrium are obliterated to interrupt the problematic pathway. However, every patient is different. For this reason, electro physiologists have to be able to discern the size and shape of the left ventricle in precise detail during the intervention. Syngo DynaCT Cardiac provides the necessary support: the software from Siemens Medical Solutions provides three-dimensional displays of the ventricle. The physician is able to view the 3-D object from all sides - even during an intervention.

During the examination, with the press of a button syngo DynaCT Cardiac delivers CTlike slice images of an organ in motion using an angiographic C-arm system. During the intervention, the physician simply moves the C-arm in a semicircle around the patient and - optionally ECG-triggered – acquires a defined number of projections. As with a CT scanner, these projections are then reconstructed into slice images and a 3D representation, which are sent to the monitor at the angiography system.

Using the new software, the electrophysiologist can create clinical acquisitions at the precise moment they are needed – during the intervention. The physician previously had to rely on clinical images taken the day before or during the patient’s last visit, usually with a CT or MRI system. However, the state of organs can change continually. Images may be already obsolete the following day, but the physician has to use them as the basis for planning the intervention.

Since its market introduction in 2004, the researchers at Siemens Medical Solutions have continued development of the syngo DynaCT software and expanded its areas of application. In addition to neuroradiological acquisitions, physicians can use syngo DynaCT to generate soft tissue images of the entire body and detect tumors. Syngo DynaCT Cardiac also displays the heart for the first time. "This is a milestone in the short but very successful history of syngo DynaCT. Once again, the software has shown its use across a wide range of applications, maintaining its position in interventional radiology and beyond," said Dr. Norbert Gaus, the head of the Angiography, Fluoroscopy, and Radiographic Systems division at Siemens Medical Solutions. Syngo DynaCT Cardiac can be used with Siemens angiography systems with flat detectors.

About Siemens Medical Solutions
Siemens Medical Solutions of Siemens AG (NYSE: SI) is one of the world's largest suppliers to the healthcare industry. The company is known for bringing together innovative medical technologies, healthcare information systems, management consulting, and support services, to help customers achieve tangible, sustainable, clinical and financial outcomes. Recent acquisitions in the area of in-vitro diagnostics - such as Diagnostic Products Corporation and Bayer Diagnostics - mark a significant milestone for Siemens as it becomes the first full service diagnostics company. Employing more than 41,000 people worldwide and operating in over 130 countries, Siemens Medical Solutions reported sales of 8.23 billion EUR, orders of 9.33 billion EUR and group profit of 1.06 billion EUR for fiscal 2006 (Sept. 30), according to U.S. GAAP. Further information can be found by visiting www.siemens.com/medical

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

AI-Human Task-Sharing could Cut Mammogra…

The most effective way to harness the power of artificial intelligence (AI) when screening for breast cancer may be through collaboration with human radiologists - not by wholesale replacing them...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...

AI Tool Uses Face Photos to Estimate Bio…

Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm...

Philips Future Health Index 2025 Report …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, "Building trust in healthcare AI," spotlighting the state of...

AI-Powered Precision: Unlocking the Futu…

A team of researchers from the Department of Diagnostic and Therapeutic Ultrasonography at the Tianjin Medical University Cancer Institute & Hospital, have published a review in Cancer Biology & Medicine...

AI Model Improves Delirium Prediction, L…

An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and...

Building Trust in Artificial Intelligenc…

A new review, published in the peer-reviewed journal AI in Precision Oncology, explores the multifaceted reasons behind the skepticism surrounding artificial intelligence (AI) technologies in healthcare and advocates for approaches...

SALSA: A New AI Tool for the Automated a…

Investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep...